Bio Weekly: $6.9M Raise, New Ignition Sales, DeSci Lending w/ Aave, RNA Molecules, Aubrai Nets $275K
This week’s highlights: $6.9M Raise anchored by Arthur Hayes, new Ignition Sales and BIO lending on Aave V3.
Highlights from last week in the Biosphere 🌐
- Bio's $6.9M Round: Bio raised $6.9M in a fundraising round anchored by Arthur Hayes' Maelstrom Fund with participation from leading biotech and crypto investors. The funding will fuel Bio's growth into a full-stack platform for AI-driven DeSci, giving researchers, patients and the crypto community new ways to build and monetize biotech discoveries outside traditional pharma structures and faster than legacy biotech. The round coincides with the introduction of new primitives like BioAgents and new onchain funding, incentive and AI-driven frameworks to early-stage scientific research & development. Press coverage in Cointelegraph, CoinDesk, TheBlock, Longevity Technology & The Associated Press (AP).
- New Ignition Sales: The second and third Ignition Sales went live on the Bio Launchpad: (), a BioAgent for personalized microbiome health & trials and (), an IP-Token exploring natural DMT production in the brain launched in partnership with a University of Florida lab. Both sales last 3 days and . In their first hours live, both sales were oversubscribed, enabling BioXP and holders who participated to receive early allocations. Both tokens will go live for secondary-market trading shortly after the sales conclude via AMM liquidity pools paired with BIO. Ignition Sale access and open market trading is available in the Bio App, via the and the .
